Free Trial

Spectral Medical (TSE:EDT) Trading Up 1.2% - Time to Buy?

Spectral Medical logo with Medical background

Key Points

  • Spectral Medical's shares increased by 1.2%, trading at C$0.82, with a trading volume of 87,509 shares—a 45% rise from the average.
  • The company has a market capitalization of C$326.25 million and reported a P/E ratio of -16.57, indicating potential challenges in profitability.
  • Spectral Medical focuses on developing treatments for septic shock through its endotoxin activity assay (EAA) diagnostic and toraymyxin therapeutic.
  • Five stocks to consider instead of Spectral Medical.

Spectral Medical Inc. (TSE:EDT - Get Free Report) shares were up 1.2% during mid-day trading on Wednesday . The stock traded as high as C$0.82 and last traded at C$0.82. Approximately 87,509 shares traded hands during mid-day trading, an increase of 45% from the average daily volume of 60,538 shares. The stock had previously closed at C$0.81.

Spectral Medical Price Performance

The stock has a market capitalization of C$312.19 million, a PE ratio of -15.86 and a beta of 0.96. The company has a debt-to-equity ratio of 26.03, a current ratio of 0.61 and a quick ratio of 0.45. The stock's fifty day moving average is C$0.84 and its 200-day moving average is C$0.78.

Spectral Medical Company Profile

(Get Free Report)

Spectral Medical Inc is focused on the development and commercialization of a treatment for septic shock utilizing its endotoxin activity assay (EAA) diagnostic and the toraymyxin therapeutic. The company also manufactures and sells proprietary reagents. The product line of the company consists of proprietary biochemical, EAA, and instrumentation.

Featured Articles

Should You Invest $1,000 in Spectral Medical Right Now?

Before you consider Spectral Medical, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Spectral Medical wasn't on the list.

While Spectral Medical currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report
Like this article? Share it with a colleague.